CELIXIR

Pharmaceutical preparations for the treatment of damaged skin, tissue, organs and body parts; pharmaceutical preparations for the treatment of diseased skin, tissue, organs and body parts in the nature of treatment for viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases; veterinary pharmaceutical preparations for the treatment of damaged or diseased skin, tissue, organs and body parts; pharmaceutical and veterinary pharmaceutical preparations for use in promoting cellular, tissue, and organ regeneration; pharmaceutical and veterinary pharmaceutical preparations for use in regenerative medicine; pharmaceutical preparations and substances for the treatment of damaged skin and tissue, namely, tissue regenerative pharmaceutical preparations; cellular medicines, namely, stem cells for medical or veterinary use